Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Largest pharma cluster in World to be launched in Telangana shortly: K T Rama Rao

Ruchika Sharma14 Nov 2022 3:30 PM IST

Hyderabad: Pharma City, the largest pharmaceutical cluster in the world, will be launched shortly here, said Telangana Minister for IT and Industries...

Uttarakhand Ayurveda and Unani Licensing Authority revokes ban on production of 5 Patanjali medicines

Ruchika Sharma14 Nov 2022 2:30 PM IST

In its earlier order, the Authority had asked Divya Pharmacy to stop the production of five of its products -- Bpgrit, Madhugrit, Thyrogrit, Lipidom...

DCGI panel to hold discussion on intranasal "Five Arms" booster dose iNCOVACC on Nov 15: Sources

Ruchika Sharma14 Nov 2022 1:30 PM IST

It has now announced that iNCOVACC (BBV154) has received approval under Restricted Use in Emergency Situation for ages 18 and above.

Strides Pharma Gets USFDA EIR for New York Plant, Inspection Closed With VAI

Strides Pharma Science biologics arm gets EMA nod for osteoporosis drug Kauliv

Ruchika Sharma14 Nov 2022 12:30 PM IST

Kauliv is a biosimilar to Forsteo (innovator product), indicated for both men and postmenopausal women with osteoporosis who are at high risk for...

Alembic Pharma gets four USFDA observations for Panelav facility

Alembic Pharma bags USFDA nod for alkylating drug Cyclophosphamide

Ruchika Sharma14 Nov 2022 11:33 AM IST

Vadodara: Drugmaker Alembic Pharmaceuticals Limited today announced that the company has received final approval from the US Food & Drug...

USFDA grants priority review to Sanofi-Regeneron Dupixent for bullous pemphigoid

Sanofi Dupixent recommended for EU approval by CHMP for prurigo nodularis treatment

Ruchika Sharma13 Nov 2022 4:30 PM IST

Dupixent is a fully human monoclonal antibody that inhibits the signaling of the interleukin-4 (IL-4) and interleukin-13 (IL-13) pathways and is not...

Pfizer Indian arm reports profit jump on lower costs, price hikes

Ruchika Sharma13 Nov 2022 3:30 PM IST

Pfizer's revenue from operations rose 0.3% to 6.38 billion rupees.

Pfizer, BioNTech get positive CHMP opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID vaccine booster for children 5 through 11 years of age in EU

Ruchika Sharma13 Nov 2022 2:00 PM IST

-New York: Pfizer Inc. and BioNTech SE have announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY...

Glenmarks Telma Surpasses Rs 1,000 Crore Revenue, Recognized in Harvard Case Study

Glenmark Pharma profit after tax rises marginally to Rs 279 crore in Q2

Ruchika Sharma13 Nov 2022 12:00 PM IST

New Delhi: Drugmaker Glenmark Pharmaceuticals on Friday said its profit after tax (PAT) rose marginally to Rs 279 crore for the second quarter...

AstraZeneca Imfinzi approved in EU as immunotherapy for limited stage small cell lung cancer

AstraZeneca tops quarterly estimates buoyed by cancer drug sales

Ruchika Sharma13 Nov 2022 10:00 AM IST

Delaware: AstraZeneca on Thursday topped analysts' expectations for third-quarter profit and revenue, helped by sales of its key cancer drugs, and...

Uttarakhand health regulator asks Patanjali unit to stop production of Bpgrit, Madhugrit and 3 other medicines

Ruchika Sharma12 Nov 2022 3:45 PM IST

New Delhi: Dehradun, Uttarakhand Ayurveda, and Unani Licensing Authority has asked Divya Pharmacy to stop the production of five medicines and produce...

Indian Medicines Pharmaceutical Corp pays Rs 10 crore dividend to stakeholders

Ruchika Sharma12 Nov 2022 2:27 PM IST

New Delhi: Indian Medicines Pharmaceutical Corporation (IMPCL), a central public sector enterprise (CPSE), under the Ministry of Ayush, Government of...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok